A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

Signe Wildt, Inge Nordgaard Lassen, Ulla Hansen, Elke Brockmann, Jüri J Rumessen

129 Citationer (Scopus)

Abstract

To investigate the clinical effect of treatment with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 (Probio-Tec AB-25) to maintain remission in patients with ulcerative colitis.
OriginalsprogEngelsk
TidsskriftJournal of Crohn's & colitis
Vol/bind5
Udgave nummer2
Sider (fra-til)115-21
Antal sider7
DOI
StatusUdgivet - 1 apr. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis'. Sammen danner de et unikt fingeraftryk.

Citationsformater